MTA1 and cancer: The dysregulation of above AS events in ATRX and MYBL2 are significantly related to mitosis (Supplementary Fig. 8b) and tumorigenesis (Supplementary Fig. 8c) in cancer patients, suggesting that MTA1 may regulate mitosis and tumorigenesis by targeting the AS of these two mitosis regulators.